163 related articles for article (PubMed ID: 37922005)
1. Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia.
Hussan SS; Ali MS; Fatima M; Altaf M; Sadaf S
Ann Hematol; 2024 Feb; 103(2):511-523. PubMed ID: 37922005
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
3. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.
Kannan S; Fang W; Song G; Mullighan CG; Hammitt R; McMurray J; Zweidler-McKay PA
Blood; 2011 Mar; 117(10):2891-900. PubMed ID: 21224467
[TBL] [Abstract][Full Text] [Related]
4. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
5. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
[TBL] [Abstract][Full Text] [Related]
7. A panel of epigenetically dysregulated Wnt signaling pathway genes for non-invasive diagnosis of pediatric acute lymphoblastic leukemia.
Hussan SS; Maqsood N; Wang Q; Tao S; Sadaf S
Cancer Biomark; 2021; 32(4):459-470. PubMed ID: 34334378
[TBL] [Abstract][Full Text] [Related]
8. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
9. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax.
Li D; Yuan Y; Meng C; Lin Z; Zhao M; Shi L; Li M; Ye D; Cai Y; He X; Ye H; Zhou S; Zhou H; Gao S
Clin Epigenetics; 2024 Mar; 16(1):48. PubMed ID: 38528641
[TBL] [Abstract][Full Text] [Related]
10. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.
Kumar V; Palermo R; Talora C; Campese AF; Checquolo S; Bellavia D; Tottone L; Testa G; Miele E; Indraccolo S; Amadori A; Ferretti E; Gulino A; Vacca A; Screpanti I
Leukemia; 2014 Dec; 28(12):2324-35. PubMed ID: 24727676
[TBL] [Abstract][Full Text] [Related]
11. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
12. Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia.
Xiong H; Mancini M; Gobert M; Shen S; Furtado GC; Lira SA; Parkhurst CN; Garambois V; Brengues M; Tadokoro CE; Trimarchi T; Gómez-López G; Singh A; Khiabanian H; Minuzzo S; Indraccolo S; Lobry C; Aifantis I; Herranz D; Lafaille JJ; Maraver A
Theranostics; 2021; 11(4):1594-1608. PubMed ID: 33408769
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function.
Wang W; Zimmerman G; Huang X; Yu S; Myers J; Wang Y; Moreton S; Nthale J; Awadallah A; Beck R; Xin W; Wald D; Huang AY; Zhou L
Cancer Res; 2016 Mar; 76(6):1641-52. PubMed ID: 26801976
[TBL] [Abstract][Full Text] [Related]
14. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
15. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
16. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.
van der Velden VH; Jacobs DC; Wijkhuijs AJ; Comans-Bitter WM; Willemse MJ; Hählen K; Kamps WA; van Wering ER; van Dongen JJ
Leukemia; 2002 Aug; 16(8):1432-6. PubMed ID: 12145681
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
19. Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.
Touzart A; Boissel N; Belhocine M; Smith C; Graux C; Latiri M; Lhermitte L; Mathieu EL; Huguet F; Lamant L; Ferrier P; Ifrah N; Macintyre E; Dombret H; Asnafi V; Spicuglia S
Haematologica; 2020 Jun; 105(6):1575-1581. PubMed ID: 31537687
[TBL] [Abstract][Full Text] [Related]
20. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
